Last 12 months
Inside the activity.
9 purchase rows · 6 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 1 |
| Dec 2025 | 1 | 2 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 1 | 0 |
| Mar 2026 | 5 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 2 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 3 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| April 06, 2023 Filed Apr 11, 2023 00:34 UTC |
Fauchon de Villeplee ChristophePresident, Scent
|
Exercise / conversionPurchased Restricted Stock Units · Derivative | 1,188 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-23-004797 · doc4.xml · derivative · entry 3 Fauchon de Villeplee Christophe · CIK 0001881680 · President, Scent 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,188 shares Expires 2023-04-06 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: The Purchase Restricted Stock Units ("PRSUs") convert to Common Stock on a one-for-one basis. F3 · shares: Reflects vesting of PRSUs granted on May 4, 2022 pursuant to the Equity Choice Plan. Read SEC document |
| April 06, 2023 Filed Apr 11, 2023 00:34 UTC |
Fauchon de Villeplee ChristophePresident, Scent
|
Exercise / conversionCommon Stock | 913 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-23-004797 · doc4.xml · nonDerivative · entry 2 Fauchon de Villeplee Christophe · CIK 0001881680 · President, Scent 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 11,065 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · price: The Restricted Stock Units ("RSUs") convert to Common Stock on a one-for-one basis. Read SEC document |
| April 06, 2023 Filed Apr 11, 2023 00:34 UTC |
Fauchon de Villeplee ChristophePresident, Scent
|
Exercise / conversionCommon Stock | 1,188 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-23-004797 · doc4.xml · nonDerivative · entry 1 Fauchon de Villeplee Christophe · CIK 0001881680 · President, Scent 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,152 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: The Purchase Restricted Stock Units ("PRSUs") convert to Common Stock on a one-for-one basis. Read SEC document |
| April 06, 2023 Filed May 6, 2023 01:43 UTC |
Yep Gregory LEVP, Chief Scientific Officer
|
Exercise / conversionRestricted Stock Units · Derivative | 2,665 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-23-005551 · doc4.xml · derivative · entry 3 Yep Gregory L · CIK 0001678363 · EVP, Chief Scientific Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 2,665 shares Expires 2023-04-06 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: The RSUs convert to Common Stock on a one-for-one basis. F1 · shares: Reflects vesting and settlement of Restricted Stock Units ("RSUs") granted on May 6, 2020 pursuant to the Equity Choice Plan ("ECP"). F2 · price: The RSUs convert to Common Stock on a one-for-one basis. Read SEC document |
| April 06, 2023 Filed May 6, 2023 01:43 UTC |
Yep Gregory LEVP, Chief Scientific Officer
|
Tax withholdingCommon Stock | 733 | $91.45 | $67,032.85 |
DisclosureSEC source: 0001225208-23-005551 · doc4.xml · nonDerivative · entry 2 Yep Gregory L · CIK 0001678363 · EVP, Chief Scientific Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,768 F3 · shares: Reflects shares withheld for taxes payable upon the vesting of RSUs. Read SEC document |
| April 06, 2023 Filed May 6, 2023 01:43 UTC |
Yep Gregory LEVP, Chief Scientific Officer
|
Exercise / conversionCommon Stock | 2,665 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-23-005551 · doc4.xml · nonDerivative · entry 1 Yep Gregory L · CIK 0001678363 · EVP, Chief Scientific Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,501 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Reflects vesting and settlement of Restricted Stock Units ("RSUs") granted on May 6, 2020 pursuant to the Equity Choice Plan ("ECP"). F2 · price: The RSUs convert to Common Stock on a one-for-one basis. Read SEC document |
| April 03, 2023 Filed Apr 4, 2023 20:09 UTC |
O'Byrne KevinDirector
|
GrantRestricted Stock Units · Derivative | 262 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-23-004498 · doc4.xml · derivative · entry 1 O'Byrne Kevin · CIK 0001969000 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 262 Underlying: Common Stock · 262 shares Expires 2023-05-04 F1 · derivative.exercise_price: The Restricted Stock Units ("RSUs") convert to Common Stock on a one-for-one basis. Read SEC document |
| April 01, 2023 Filed Apr 5, 2023 20:08 UTC |
Herriott SimonPresident Health & Biosciences
|
Exercise / conversionRestricted Stock Units · Derivative | 1,489 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-23-004674 · doc4.xml · derivative · entry 3 Herriott Simon · CIK 0001843592 · President Health & Biosciences 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,489 Underlying: Common Stock · 1,489 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: The RSUs convert to Common Stock on a one-for-one basis. F1 · shares: Reflects vesting and settlement of Restricted Stock Units ("RSUs") granted on April 1, 2022. F2 · price: The RSUs convert to Common Stock on a one-for-one basis. F5 · derivative.exercise_date: The RSUs vested on April 1, 2023. F5 · derivative.expiration_date: The RSUs vested on April 1, 2023. Read SEC document |
| April 01, 2023 Filed Apr 5, 2023 20:08 UTC |
Herriott SimonPresident Health & Biosciences
|
Tax withholdingCommon Stock | 461 | $90.60 | $41,766.60 |
DisclosureSEC source: 0001225208-23-004674 · doc4.xml · nonDerivative · entry 2 Herriott Simon · CIK 0001843592 · President Health & Biosciences 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,432.74 F3 · shares: Reflects shares withheld for taxes payable upon the vesting of RSUs. F4 · balance_after: Includes shares acquired during the period pursuant to a dividend reinvestment plan. The transactions were exempt pursuant to Rule 16a-11. Read SEC document |
| April 01, 2023 Filed Apr 5, 2023 20:08 UTC |
Herriott SimonPresident Health & Biosciences
|
Exercise / conversionCommon Stock | 1,489 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-23-004674 · doc4.xml · nonDerivative · entry 1 Herriott Simon · CIK 0001843592 · President Health & Biosciences 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,893.74 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Reflects vesting and settlement of Restricted Stock Units ("RSUs") granted on April 1, 2022. F2 · price: The RSUs convert to Common Stock on a one-for-one basis. Read SEC document |
| March 24, 2023 Filed Mar 25, 2026 21:14 UTC |
Costa Mark JDirector
|
PurchaseCommon Stock | 10 | $84.27 | $842.70 |
DisclosureSEC source: 0001225208-26-004019 · doc4.xml · nonDerivative · entry 1 Costa Mark J · CIK 0001364708 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10 F1 · ownership.direct: During the periods presented, the Reporting Person inadvertently acquired and disposed of, as applicable, the number of shares and on the dates indicated above via automated transactions through a tax loss harvesting account. Such transactions were made under the Reporting Person's broker's (the "Broker") sole discretion and the Reporting Person had no control or authority over trading decisions. The Broker made the decisions to purchase and sell the subject shares and the Reporting Person was not aware of these very small transactions until recently. The result of these small transactions were losses for the Reporting Person. Read SEC document |
| March 01, 2023 Filed Mar 2, 2023 21:39 UTC |
Willoughby Dawn CDirector
|
GrantRestricted Stock Units · Derivative | 434 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-23-003151 · doc4.xml · derivative · entry 1 Willoughby Dawn C · CIK 0001565196 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 434 Underlying: Common Stock · 434 shares Expires 2023-05-04 F1 · derivative.exercise_price: The Restricted Stock Units ("RSUs") convert to Common Stock on a one-for-one basis. Read SEC document |
| March 01, 2023 Filed Mar 2, 2023 21:38 UTC |
Hu GaoxiangDirector
|
GrantRestricted Stock Units · Derivative | 434 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-23-003150 · doc4.xml · derivative · entry 1 Hu Gaoxiang · CIK 0001839091 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 434 Underlying: Common Stock · 434 shares Expires 2023-05-04 F1 · derivative.exercise_price: The Restricted Stock Units ("RSUs") convert to Common Stock on a one-for-one basis. Read SEC document |
| March 01, 2023 Filed Mar 2, 2023 21:38 UTC |
Clyburn FrankChief Executive Officer
|
Exercise / conversionRestricted Deferred Stock Units · Derivative | 1,323 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-23-003149 · doc4.xml · derivative · entry 3 Clyburn Frank · CIK 0001763963 · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,296 Underlying: Common Stock · 1,323 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: The DSUs convert to Common Stock on a one-for-one basis. F1 · shares: Reflects vesting and settlement of Deferred Restricted Stock Units ("DSUs") granted on March 1, 2022. F2 · price: The DSUs convert to Common Stock on a one-for-one basis. F4 · derivative.exercise_date: The DSUs vested on March 1, 2023. F4 · derivative.expiration_date: The DSUs vested on March 1, 2023. Read SEC document |
| March 01, 2023 Filed Mar 2, 2023 21:38 UTC |
Clyburn FrankChief Executive Officer
|
Tax withholdingCommon Stock | 477 | $91.64 | $43,712.28 |
DisclosureSEC source: 0001225208-23-003149 · doc4.xml · nonDerivative · entry 2 Clyburn Frank · CIK 0001763963 · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 846 F3 · shares: Reflects shares withheld for taxes payable upon the vesting of DSUs. Read SEC document |
| March 01, 2023 Filed Mar 2, 2023 21:38 UTC |
Clyburn FrankChief Executive Officer
|
Exercise / conversionCommon Stock | 1,323 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-23-003149 · doc4.xml · nonDerivative · entry 1 Clyburn Frank · CIK 0001763963 · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,323 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Reflects vesting and settlement of Deferred Restricted Stock Units ("DSUs") granted on March 1, 2022. F2 · price: The DSUs convert to Common Stock on a one-for-one basis. Read SEC document |
| February 19, 2023 Filed Feb 21, 2023 21:09 UTC |
Herriott SimonPresident Health & Biosciences
|
Exercise / conversionRestricted Stock Units · Derivative | 617 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-23-002351 · doc4.xml · derivative · entry 3 Herriott Simon · CIK 0001843592 · President Health & Biosciences 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,978 Underlying: Common Stock · 617 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: The RSUs convert to Common Stock on a one-for-one basis. F1 · shares: Reflects vesting and settlement of Restricted Stock Units ("RSUs") granted on February 19, 2020. F2 · price: The RSUs convert to Common Stock on a one-for-one basis. F4 · derivative.exercise_date: The RSUs vested on February 19, 2023. F4 · derivative.expiration_date: The RSUs vested on February 19, 2023. Read SEC document |
| February 19, 2023 Filed Feb 21, 2023 21:09 UTC |
Herriott SimonPresident Health & Biosciences
|
Tax withholdingCommon Stock | 177 | $96.13 | $17,015.01 |
DisclosureSEC source: 0001225208-23-002351 · doc4.xml · nonDerivative · entry 2 Herriott Simon · CIK 0001843592 · President Health & Biosciences 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,367.756 F3 · shares: Reflects shares withheld for taxes payable upon the vesting of RSUs. Read SEC document |
| February 19, 2023 Filed Feb 21, 2023 21:09 UTC |
Herriott SimonPresident Health & Biosciences
|
Exercise / conversionCommon Stock | 617 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-23-002351 · doc4.xml · nonDerivative · entry 1 Herriott Simon · CIK 0001843592 · President Health & Biosciences 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,544.756 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Reflects vesting and settlement of Restricted Stock Units ("RSUs") granted on February 19, 2020. F2 · price: The RSUs convert to Common Stock on a one-for-one basis. Read SEC document |
| February 19, 2023 Filed Feb 21, 2023 21:08 UTC |
Strzelecki AngelaPresident, Pharma Solutions
|
Exercise / conversionRestricted Stock Units · Derivative | 584 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-23-002348 · doc4.xml · derivative · entry 3 Strzelecki Angela · CIK 0001843595 · President, Pharma Solutions 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,341 Underlying: Common Stock · 584 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: The RSUs convert to Common Stock on a one-for-one basis. F1 · shares: Reflects vesting and settlement of Restricted Stock Units ("RSUs") granted on February 19, 2020. F2 · price: The RSUs convert to Common Stock on a one-for-one basis. F4 · derivative.exercise_date: The RSUs vested on February 19, 2023. F4 · derivative.expiration_date: The RSUs vested on February 19, 2023. Read SEC document |
| February 19, 2023 Filed Feb 21, 2023 21:08 UTC |
Strzelecki AngelaPresident, Pharma Solutions
|
Tax withholdingCommon Stock | 176 | $96.13 | $16,918.88 |
DisclosureSEC source: 0001225208-23-002348 · doc4.xml · nonDerivative · entry 2 Strzelecki Angela · CIK 0001843595 · President, Pharma Solutions 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,077 F3 · shares: Reflects shares withheld for taxes payable upon the vesting of RSUs. Read SEC document |
| February 19, 2023 Filed Feb 21, 2023 21:08 UTC |
Strzelecki AngelaPresident, Pharma Solutions
|
Exercise / conversionCommon Stock | 584 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-23-002348 · doc4.xml · nonDerivative · entry 1 Strzelecki Angela · CIK 0001843595 · President, Pharma Solutions 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,253 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Reflects vesting and settlement of Restricted Stock Units ("RSUs") granted on February 19, 2020. F2 · price: The RSUs convert to Common Stock on a one-for-one basis. Read SEC document |
| February 19, 2023 Filed Feb 21, 2023 21:08 UTC |
Johnson Jennifer AmyEVP, General Counsel
|
Exercise / conversionRestricted Stock Units · Derivative | 708 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-23-002349 · doc4.xml · derivative · entry 3 Johnson Jennifer Amy · CIK 0001844366 · EVP, General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,041 Underlying: Common Stock · 708 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: The RSUs convert to Common Stock on a one-for-one basis. F1 · shares: Reflects vesting and settlement of Restricted Stock Units ("RSUs") granted on February 19, 2020. F2 · price: The RSUs convert to Common Stock on a one-for-one basis. F4 · derivative.exercise_date: The RSUs vested on February 19, 2023. F4 · derivative.expiration_date: The RSUs vested on February 19, 2023. Read SEC document |
| February 19, 2023 Filed Feb 21, 2023 21:08 UTC |
Johnson Jennifer AmyEVP, General Counsel
|
Tax withholdingCommon Stock | 293 | $96.13 | $28,166.09 |
DisclosureSEC source: 0001225208-23-002349 · doc4.xml · nonDerivative · entry 2 Johnson Jennifer Amy · CIK 0001844366 · EVP, General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,418 F3 · shares: Reflects shares withheld for taxes payable upon the vesting of RSUs. Read SEC document |
| February 19, 2023 Filed Feb 21, 2023 21:08 UTC |
Johnson Jennifer AmyEVP, General Counsel
|
Exercise / conversionCommon Stock | 708 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-23-002349 · doc4.xml · nonDerivative · entry 1 Johnson Jennifer Amy · CIK 0001844366 · EVP, General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,711 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Reflects vesting and settlement of Restricted Stock Units ("RSUs") granted on February 19, 2020. F2 · price: The RSUs convert to Common Stock on a one-for-one basis. Read SEC document |
| February 01, 2023 Filed Feb 2, 2023 21:06 UTC |
Costa Mark JDirector
|
GrantRestricted Stock Units · Derivative | 468 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-23-001182 · doc4.xml · derivative · entry 1 Costa Mark J · CIK 0001364708 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 468 Underlying: Common Stock · 468 shares Expires 2023-05-03 F1 · derivative.exercise_price: The Restricted Stock Units ("RSUs") convert to Common Stock on a one-for-one basis. Read SEC document |
| January 24, 2023 Filed Jan 25, 2023 21:06 UTC |
DUCKER MICHAEL LDirector
|
Exercise / conversionStock Equivalent Unit · Derivative | 2,209.638 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-23-000855 · doc4.xml · derivative · entry 2 DUCKER MICHAEL L · CIK 0001188170 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 2,209.638 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Represents Stock Equivalent Units (the "Units") acquired under the Company's deferred compensation plan (the "DCP") previously reported. Each Unit converts to Common Stock on a one-for-one basis. On January 24, 2023, the Units were distributed from the DCP for an equal number of shares of Common Stock. F2 · shares: Includes Units acquired during the period upon reinvestment of dividends under the Company's deferred compensation plan since the last report. The transactions were exempt pursuant to Rule 16a-11. F1 · derivative.exercise_date: Represents Stock Equivalent Units (the "Units") acquired under the Company's deferred compensation plan (the "DCP") previously reported. Each Unit converts to Common Stock on a one-for-one basis. On January 24, 2023, the Units were distributed from the DCP for an equal number of shares of Common Stock. F1 · derivative.expiration_date: Represents Stock Equivalent Units (the "Units") acquired under the Company's deferred compensation plan (the "DCP") previously reported. Each Unit converts to Common Stock on a one-for-one basis. On January 24, 2023, the Units were distributed from the DCP for an equal number of shares of Common Stock. Read SEC document |
| January 24, 2023 Filed Jan 25, 2023 21:06 UTC |
DUCKER MICHAEL LDirector
|
Exercise / conversionCommon Stock | 2,209.638 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-23-000855 · doc4.xml · nonDerivative · entry 1 DUCKER MICHAEL L · CIK 0001188170 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,877.638 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Represents Stock Equivalent Units (the "Units") acquired under the Company's deferred compensation plan (the "DCP") previously reported. Each Unit converts to Common Stock on a one-for-one basis. On January 24, 2023, the Units were distributed from the DCP for an equal number of shares of Common Stock. Read SEC document |
| January 03, 2023 Filed Jan 6, 2023 02:27 UTC |
Fortanet FranciscoEVP, Operations
|
Exercise / conversionPurchased Restricted Stock Units · Derivative | 5,254 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-23-000436 · doc4.xml · derivative · entry 4 Fortanet Francisco · CIK 0001351377 · EVP, Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 5,254 shares Expires 2023-04-06 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: The PRSUs convert to Common Stock on a one-for-one basis. F1 · shares: Reflects vesting of Purchased Restricted Stock Units ("PRSUs") granted on May 6, 2020 pursuant to the Equity Choice Plan. Read SEC document |
| January 03, 2023 Filed Jan 6, 2023 02:27 UTC |
Fortanet FranciscoEVP, Operations
|
Tax withholdingCommon Stock | 2,229 | $103.11 | $229,832.19 |
DisclosureSEC source: 0001225208-23-000436 · doc4.xml · nonDerivative · entry 2 Fortanet Francisco · CIK 0001351377 · EVP, Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,262.729 F3 · shares: Reflects shares withheld for taxes payable upon the vesting of PRSUs. Read SEC document |
| January 03, 2023 Filed Jan 6, 2023 02:27 UTC |
Fortanet FranciscoEVP, Operations
|
Exercise / conversionCommon Stock | 5,254 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-23-000436 · doc4.xml · nonDerivative · entry 1 Fortanet Francisco · CIK 0001351377 · EVP, Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,491.729 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Reflects vesting of Purchased Restricted Stock Units ("PRSUs") granted on May 6, 2020 pursuant to the Equity Choice Plan. F2 · price: The PRSUs convert to Common Stock on a one-for-one basis. Read SEC document |
| January 03, 2023 Filed Jan 6, 2023 02:28 UTC |
Strzelecki AngelaPresident, Pharma Solutions
|
Exercise / conversionRestricted Stock Units · Derivative | 1,341 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-23-000437 · doc4.xml · derivative · entry 3 Strzelecki Angela · CIK 0001843595 · President, Pharma Solutions 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,925 Underlying: Common Stock · 1,341 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: The RSUs convert to Common Stock on a one-for-one basis. F1 · shares: Reflects vesting and settlement of Restricted Stock Units ("RSUs") granted on January 3, 2022. F2 · price: The RSUs convert to Common Stock on a one-for-one basis. F4 · derivative.exercise_date: The RSUs vested on January 3, 2023. F4 · derivative.expiration_date: The RSUs vested on January 3, 2023. Read SEC document |
| January 03, 2023 Filed Jan 6, 2023 02:28 UTC |
Strzelecki AngelaPresident, Pharma Solutions
|
Tax withholdingCommon Stock | 487 | $105.64 | $51,446.68 |
DisclosureSEC source: 0001225208-23-000437 · doc4.xml · nonDerivative · entry 2 Strzelecki Angela · CIK 0001843595 · President, Pharma Solutions 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,669 F3 · shares: Reflects shares withheld for taxes payable upon the vesting of RSUs. Read SEC document |
| January 03, 2023 Filed Jan 6, 2023 02:28 UTC |
Strzelecki AngelaPresident, Pharma Solutions
|
Exercise / conversionCommon Stock | 1,341 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-23-000437 · doc4.xml · nonDerivative · entry 1 Strzelecki Angela · CIK 0001843595 · President, Pharma Solutions 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,156 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Reflects vesting and settlement of Restricted Stock Units ("RSUs") granted on January 3, 2022. F2 · price: The RSUs convert to Common Stock on a one-for-one basis. Read SEC document |
| January 03, 2023 Filed Jan 6, 2023 02:26 UTC |
Fauchon de Villeplee ChristophePresident, Scent
|
Exercise / conversionRestricted Stock Units · Derivative | 784 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-23-000435 · doc4.xml · derivative · entry 2 Fauchon de Villeplee Christophe · CIK 0001881680 · President, Scent 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 784 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: The Restricted Stock Units ("RSUs") convert to Common Stock on a one-for-one basis. F2 · shares: Reflects vesting and settlement of RSUs granted on January 2, 2020. F3 · derivative.exercise_date: The RSUs vested on January 2, 2023. F3 · derivative.expiration_date: The RSUs vested on January 2, 2023. Read SEC document |
| January 03, 2023 Filed Jan 6, 2023 02:26 UTC |
Fauchon de Villeplee ChristophePresident, Scent
|
Exercise / conversionCommon Stock | 784 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-23-000435 · doc4.xml · nonDerivative · entry 1 Fauchon de Villeplee Christophe · CIK 0001881680 · President, Scent 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,964 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: The Restricted Stock Units ("RSUs") convert to Common Stock on a one-for-one basis. Read SEC document |
| December 31, 2022 Filed Jan 7, 2023 00:24 UTC |
MIRZAYANTZ NICOLASPresident, Nourish
|
Disposition to issuerRestricted Stock Units · Derivative | 1,843 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-23-000466 · doc4.xml · derivative · entry 3 MIRZAYANTZ NICOLAS · CIK 0001211907 · President, Nourish 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,701 Underlying: Common Stock · 1,843 shares Expires 2024-05-05 F4 · derivative.exercise_price: The Restricted Stock Units ("RSUs") convert to Common Stock on a one-for-one basis. F3 · derivative.underlying_shares: Both PSUs and RSUs have been awarded by the Company pro rata in connection with the time the reporting person was with the Company, the rest were disposed of by the Company. Read SEC document |
| December 31, 2022 Filed Jan 7, 2023 00:24 UTC |
MIRZAYANTZ NICOLASPresident, Nourish
|
Disposition to issuerPurchased Restricted Stock Units · Derivative | 1,962 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-23-000466 · doc4.xml · derivative · entry 2 MIRZAYANTZ NICOLAS · CIK 0001211907 · President, Nourish 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,600 Underlying: Common Stock · 1,962 shares Expires 2024-04-05 F1 · derivative.exercise_price: The Purchased Restricted Stock Units ("PRSUs") convert to Common Stock on a one-for-one basis. F2 · shares: Represents matching grant of PRSUs under the Equity Choice Program, all of which would have vested on April 5, 2024. F3 · derivative.underlying_shares: Both PSUs and RSUs have been awarded by the Company pro rata in connection with the time the reporting person was with the Company, the rest were disposed of by the Company. Read SEC document |
| December 01, 2022 Filed Dec 2, 2022 21:05 UTC |
Finzel RalfEVP, Global Operations Officer
|
GrantRestricted Stock Units · Derivative | 21,548 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-22-012165 · doc4.xml · derivative · entry 1 Finzel Ralf · CIK 0001952188 · EVP, Global Operations Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,548 Underlying: Common Stock · 21,548 shares Expires not disclosed F1 · derivative.exercise_price: The Restricted Stock Units ("RSUs") convert to Common Stock on a one-for-one basis. F2 · derivative.exercise_date: 25% of each of the RSUs will vest on each of December 1, 2023 and December 1, 2024, and 50% will vest on December 1, 2025, in each case subject to the reporting person's continued employment with the Company. F2 · derivative.expiration_date: 25% of each of the RSUs will vest on each of December 1, 2023 and December 1, 2024, and 50% will vest on December 1, 2025, in each case subject to the reporting person's continued employment with the Company. Read SEC document |
| November 01, 2022 Filed Nov 3, 2022 20:39 UTC |
MORRISON DALE FDirector
|
GrantStock Equivalent Unit · Derivative | 1,807.229 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-22-011340 · doc4.xml · derivative · entry 2 MORRISON DALE F · CIK 0001179158 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,876.949 Underlying: Common Stock · 1,807.229 shares Expires not disclosed F1 · derivative.exercise_price: The Stock Equivalent Units ("Units") convert to Common Stock on a one-for-one basis. F2 · shares: Units under the Company's deferred compensation plan resulting from deferral of director fees. F3 · derivative.exercise_date: The Units are payable in Common Stock upon the reporting person ceasing to serve as a member of the Company's Board of Directors. F3 · derivative.expiration_date: The Units are payable in Common Stock upon the reporting person ceasing to serve as a member of the Company's Board of Directors. F4 · balance_after: Includes Units acquired during the period upon reinvestment of dividends under the Company's deferred compensation plan during 2022. The transactions were exempt pursuant to Rule 16a-11. Read SEC document |
| November 01, 2022 Filed Nov 3, 2022 20:33 UTC |
Williamson StephenDirector
|
GrantStock Equivalent Unit · Derivative | 1,178.628 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-22-011328 · doc4.xml · derivative · entry 1 Williamson Stephen · CIK 0001648929 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,562.883 Underlying: Common Stock · 1,178.628 shares Expires not disclosed F1 · derivative.exercise_price: The Stock Equivalent Units ("Units") convert to Common Stock on a one-for-one basis. F2 · shares: Units under the Company's deferred compensation plan resulting from deferral of director fees. F3 · derivative.exercise_date: The Units are payable in Common Stock upon the reporting person ceasing to serve as a member of the Company's Board of Directors. F3 · derivative.expiration_date: The Units are payable in Common Stock upon the reporting person ceasing to serve as a member of the Company's Board of Directors. F4 · balance_after: Includes Units acquired during the period upon reinvestment of dividends under the Company's deferred compensation plan during 2022. The transactions were exempt pursuant to Rule 16a-11. Read SEC document |
| November 01, 2022 Filed Nov 3, 2022 20:29 UTC |
Johnson Jennifer AmyEVP, General Counsel
|
Exercise / conversionRestricted Stock Units · Derivative | 1,041 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-22-011326 · doc4.xml · derivative · entry 3 Johnson Jennifer Amy · CIK 0001844366 · EVP, General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,749 Underlying: Common Stock · 1,041 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: The RSUs convert to Common Stock on a one-for-one basis. F1 · shares: Reflects vesting and settlement of Restricted Stock Units ("RSUs") granted on November 1, 2021. F2 · price: The RSUs convert to Common Stock on a one-for-one basis. F4 · derivative.exercise_date: The RSUs vested on November 1, 2022. F4 · derivative.expiration_date: The RSUs vested on November 1, 2022. Read SEC document |
| November 01, 2022 Filed Nov 3, 2022 20:29 UTC |
Johnson Jennifer AmyEVP, General Counsel
|
Tax withholdingCommon Stock | 376 | $95.45 | $35,889.20 |
DisclosureSEC source: 0001225208-22-011326 · doc4.xml · nonDerivative · entry 2 Johnson Jennifer Amy · CIK 0001844366 · EVP, General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,003 F3 · shares: Reflects shares withheld for taxes payable upon the vesting of RSUs. Read SEC document |
| November 01, 2022 Filed Nov 3, 2022 20:29 UTC |
Johnson Jennifer AmyEVP, General Counsel
|
Exercise / conversionCommon Stock | 1,041 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-22-011326 · doc4.xml · nonDerivative · entry 1 Johnson Jennifer Amy · CIK 0001844366 · EVP, General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,379 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Reflects vesting and settlement of Restricted Stock Units ("RSUs") granted on November 1, 2021. F2 · price: The RSUs convert to Common Stock on a one-for-one basis. Read SEC document |
| October 03, 2022 Filed Oct 4, 2022 20:16 UTC | Exercise / conversionRestricted Stock Units · Derivative | 11,812 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-22-010684 · doc4.xml · derivative · entry 2 RICHTER GLENN R · CIK 0001200237 · CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,624 Underlying: Common Stock · 11,812 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: The RSUs convert to Common Stock on a one-for-one basis. F1 · shares: Reflects vesting and settlement of Restricted Stock Units ("RSUs") granted on October 1, 2021. F3 · derivative.exercise_date: The RSUs vested on October 1, 2022. F3 · derivative.expiration_date: The RSUs vested on October 1, 2022. Read SEC document |
|
| October 03, 2022 Filed Oct 4, 2022 20:16 UTC | Exercise / conversionCommon Stock | 11,812 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-22-010684 · doc4.xml · nonDerivative · entry 1 RICHTER GLENN R · CIK 0001200237 · CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,812 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Reflects vesting and settlement of Restricted Stock Units ("RSUs") granted on October 1, 2021. F2 · price: The RSUs convert to Common Stock on a one-for-one basis. Read SEC document |
|
| October 03, 2022 Filed Oct 4, 2022 20:11 UTC |
Yildiz BerilCAO, SVP & Controller
|
GrantRestricted Stock Units · Derivative | 2,155 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-22-010681 · doc4.xml · derivative · entry 1 Yildiz Beril · CIK 0001887484 · CAO, SVP & Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,155 Underlying: Common Stock · 2,155 shares Expires not disclosed F1 · derivative.exercise_price: The Restricted Stock Units ("RSUs") convert to Common Stock on a one-for-one basis. F2 · derivative.exercise_date: Fifty percent of each of the RSUs will vest on October 3, 2023 and October 3, 2024, in each case subject to the reporting person's continued employment with the Company. F2 · derivative.expiration_date: Fifty percent of each of the RSUs will vest on October 3, 2023 and October 3, 2024, in each case subject to the reporting person's continued employment with the Company. Read SEC document |
| September 01, 2022 Filed Sep 6, 2022 20:24 UTC |
Borg DeborahEVP, Chief HR and D&I Officer
|
GrantRestricted Stock Units · Derivative | 4,602 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-22-010056 · doc4.xml · derivative · entry 3 Borg Deborah · CIK 0001663373 · EVP, Chief HR and D&I Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 59,831 Underlying: Common Stock · 4,602 shares Expires not disclosed F1 · derivative.exercise_price: The Restricted Stock Units ("RSUs") convert to Common Stock on a one-for-one basis. F3 · derivative.exercise_date: Represents RSUs granted under the Company's 2021 Stock Award and Incentive Plan, which vest and expire on April 4, 2025. F3 · derivative.expiration_date: Represents RSUs granted under the Company's 2021 Stock Award and Incentive Plan, which vest and expire on April 4, 2025. Read SEC document |
| September 01, 2022 Filed Sep 6, 2022 20:24 UTC |
Borg DeborahEVP, Chief HR and D&I Officer
|
GrantRestricted Stock Units · Derivative | 9,205 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-22-010056 · doc4.xml · derivative · entry 2 Borg Deborah · CIK 0001663373 · EVP, Chief HR and D&I Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 55,229 Underlying: Common Stock · 9,205 shares Expires not disclosed F1 · derivative.exercise_price: The Restricted Stock Units ("RSUs") convert to Common Stock on a one-for-one basis. F2 · derivative.exercise_date: Fifty percent of each of the RSUs will vest on September 1, 2023, and 25% will vest on each of September 1, 2024 and September 1, 2025. F2 · derivative.expiration_date: Fifty percent of each of the RSUs will vest on September 1, 2023, and 25% will vest on each of September 1, 2024 and September 1, 2025. Read SEC document |
| September 01, 2022 Filed Sep 6, 2022 20:24 UTC |
Borg DeborahEVP, Chief HR and D&I Officer
|
GrantRestricted Stock Units · Derivative | 46,024 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-22-010056 · doc4.xml · derivative · entry 1 Borg Deborah · CIK 0001663373 · EVP, Chief HR and D&I Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 46,024 Underlying: Common Stock · 46,024 shares Expires not disclosed F1 · derivative.exercise_price: The Restricted Stock Units ("RSUs") convert to Common Stock on a one-for-one basis. F2 · derivative.exercise_date: Fifty percent of each of the RSUs will vest on September 1, 2023, and 25% will vest on each of September 1, 2024 and September 1, 2025. F2 · derivative.expiration_date: Fifty percent of each of the RSUs will vest on September 1, 2023, and 25% will vest on each of September 1, 2024 and September 1, 2025. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.